Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1990 6
1991 4
1992 2
1993 2
1995 4
1996 2
1997 8
1998 2
1999 1
2000 1
2001 1
2002 2
2003 3
2004 8
2005 7
2006 5
2007 6
2009 3
2010 2
2011 3
2012 1
2013 1
2014 3
2015 2
2018 2
2020 2
2021 3
2022 1
2023 3
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.
Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Kozesinski-Nakatani AC, David-João PG, Lobo SM, Filiponi TC, Almeida GMB, Bergo RR, Guimarães-Júnior MRR, Figueiredo RC, Castro JR, Schuler CJ, Westphal GA, Carioca ACR, Monfradini F, Nieri J, Neves FMO, Paulo JA, Albuquerque CSN, Silva MCR, Kosiborod MN, Pereira AJ, Damiani LP, Corrêa TD, Serpa-Neto A, Berwanger O, Zampieri FG; DEFENDER Investigators. Tavares CAM, et al. JAMA. 2024 Aug 6;332(5):401-411. doi: 10.1001/jama.2024.10510. JAMA. 2024. PMID: 38873723 Clinical Trial.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, et al. JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330. JAMA. 2021. PMID: 34228774 Free PMC article.
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, Barbosa LM, de Aveiro Morata J, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS, Ritt LEF, Rocha AT, Tramujas L, Santos SV, Diaz DRA, Viana LS, Melro LMG, de Alcântara Chaud MS, Figueiredo EL, Neuenschwander FC, Dracoulakis MDA, Lima RGSD, de Souza Dantas VC, Fernandes ACS, Gebara OCE, Hernandes ME, Queiroz DAR, Veiga VC, Canesin MF, de Faria LM, Feitosa-Filho GS, Gazzana MB, Liporace IL, de Oliveira Twardowsky A, Maia LN, Machado FR, de Matos Soeiro A, Conceição-Souza GE, Armaganijan L, Guimarães PO, Rosa RG, Azevedo LCP, Alexander JH, Avezum A, Cavalcanti AB, Berwanger O; ACTION Coalition COVID-19 Brazil IV Investigators. Lopes RD, et al. Among authors: gebara oce. Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4. Lancet. 2021. PMID: 34097856 Free PMC article. Clinical Trial.
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investigators. Cavalcanti AB, et al. Among authors: gebara oce. N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23. N Engl J Med. 2020. PMID: 32706953 Free PMC article. Clinical Trial.
Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.
de Barros E Silva PGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, Suiama MA, Antunes MO, Gonçalves MR, Gebara OCE, de Aquino Martins P, Ribeiro MG, de Moura Xavier de Moraes JB Jr, Aguiar VCR, Cavalcanti AB, Rosa RG, Berwanger O, Veiga VC, Azevedo LCP, Ramacciotti E, Granger CB, Alexander JH, Avezum A, Lopes RD; Coalition COVID-19 Brazil Investigators. de Barros E Silva PGM, et al. Among authors: gebara oce. Circulation. 2024 Jul 2;150(1):82-85. doi: 10.1161/CIRCULATIONAHA.123.066709. Epub 2024 Jul 1. Circulation. 2024. PMID: 38950107 Clinical Trial. No abstract available.
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Bergo RR, Kozesinski-Nakatani AC, David-João PG, Westphal GA, Guimarães Júnior MRR, Lobo SMA, Tavares MS, Dracoulakis MDA, Souza GM, Almeida GMB, Gebara OCE, Tomba PO, Albuquerque CSN, Silva MCR, Pereira AJ, Damiani LP, Corrêa TD, Serpa-Neto A, Berwanger O, Zampieri FG. Tavares CAM, et al. Among authors: gebara oce. Crit Care Sci. 2023 Dec 22;35(3):256-265. doi: 10.5935/2965-2774.20230129-en. eCollection 2023. Crit Care Sci. 2023. PMID: 38133155 Free PMC article.
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials.
Furtado RHM, Barros E Silva PGM, Fonseca HAR, Serpa-Neto A, Correa TD, Guimarães HP, Pereira AJ, Olivato GB, Zampieri FG, Lisboa T, Junqueira DLM, Lapa MG, Monfardini F, Damiani LP, Echenique LS, Gebara OE, Hoffman Filho CR, Polanczyk CA, Rohde LE, Amazonas R, Machado FR, Avezum A, Azevedo LCP, Veiga VC, Rosa RG, Lopes RD, Cavalcanti AB, Berwanger O; COALITION COVID-19 Brazil Steering Committee and Investigators. Furtado RHM, et al. Among authors: gebara oe. Am J Cardiol. 2024 Mar 1;214:18-24. doi: 10.1016/j.amjcard.2023.11.069. Epub 2023 Dec 15. Am J Cardiol. 2024. PMID: 38104755 Clinical Trial.
[Noncompaction of the myocardium].
Rodrigues GH, Parga Filho JR, Pierri H, Serro-Azul JB, Gebara OC, Nussbacher A, Rays J. Rodrigues GH, et al. Among authors: gebara oc. Rev Assoc Med Bras (1992). 2004 Oct-Dec;50(4):360. doi: 10.1590/s0104-42302004000400019. Epub 2005 Jan 14. Rev Assoc Med Bras (1992). 2004. PMID: 15666010 Free article. Portuguese. No abstract available.
[Cardiovascular effects of testosterone].
Gebara OC, Vieira NW, Meyer JW, Calich AL, Tai EJ, Pierri H, Wajngarten M, Aldrighi JM. Gebara OC, et al. Arq Bras Cardiol. 2002 Dec;79(6):644-9. doi: 10.1590/s0066-782x2002001500013. Epub 2003 Jan 9. Arq Bras Cardiol. 2002. PMID: 12532251 Free article. Portuguese. No abstract available.
Predictors of subclinical carotid atherosclerosis in middle-aged women.
de Barros IL, Costa L, Bezerra B, Gomes R, Morais N, Strunz CMC, Novaes M, Gebara OCE, Pedrosa RP, Nicolau JC. de Barros IL, et al. Among authors: gebara oce. PLoS One. 2018 May 23;13(5):e0197582. doi: 10.1371/journal.pone.0197582. eCollection 2018. PLoS One. 2018. PMID: 29791465 Free PMC article.
93 results